Research Collaboration PRC operates as an FDA-regulated clinical research facility focused on adult and pediatric allergy and asthma. Led by Drs. Gary Gross and Michael Ruff, it offers a ready site for pharmaceutical sponsors seeking access to North Texas patients and streamlined recruitment through the DAAC patient base.

Pediatric Leadership DAAC includes a dedicated pediatric allergist and a long-standing footprint in North Dallas, presenting a compelling option for sponsors needing pediatric allergy and immunology trial sites and strategic access to families.

Small Team Advantage With a lean staff of 2-10, DAAC can deliver personalized patient engagement and fast study startup, though capacity limits may require scalable CRO support or partnerships for larger trials.

Niche Positioning Combining allergy and asthma care with pharmaceutical research, DAAC occupies a specialized niche in North Texas that can support targeted allergology studies and post-marketing research in a local market.

Digital Readiness Current tech stack appears to be basic (GoDaddy); opportunity exists to modernize digital presence, patient portal, and trial recruitment workflows with HIPAA-compliant EHR/CRM and telemedicine capabilities to improve patient enrollment and retention in studies.